Irene Ramos, PhD is an Assistant Professor at the Icahn School of Medicine at Mount Sinai. Her research focuses on the study of innate and adaptive immune responses to virus infections, such as Influenza A Virus (IAV) and the pandemic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). She has done extensive work on the evaluation of the effects of several virulence factors of IAV in human primary cells, using ex vivo human systems and single-cell technologies, such as single-cell transcriptomics or mass cytometry. She has contributed to our understanding of the establishment and durability of the antibody response to SARS-CoV-2 virus in asymptomatic individuals and patients with mild disease, as well as to other important aspects of the immunology and epidemiology such as identification of serological correlates of protection, virus transmission, and epigenomic and transcriptomic profiling. Additionally, she is interested in vaccines against virus infections, and has actively participated in several studies analyzing the immune response to influenza and SARS-CoV-2 vaccines.
Research Keywords & Expertise
Dendritic Cells
Innate Immunity
Influenza Virus
SARS-CoV-2
Antibody response to i...
Single-cell profiling ...
Fingerprints
43%
SARS-CoV-2
25%
Influenza Virus
23%
Innate Immunity
12%
Dendritic Cells
8%
Antibody response to infection
Short Biography
Irene Ramos, PhD is an Assistant Professor at the Icahn School of Medicine at Mount Sinai. Her research focuses on the study of innate and adaptive immune responses to virus infections, such as Influenza A Virus (IAV) and the pandemic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). She has done extensive work on the evaluation of the effects of several virulence factors of IAV in human primary cells, using ex vivo human systems and single-cell technologies, such as single-cell transcriptomics or mass cytometry. She has contributed to our understanding of the establishment and durability of the antibody response to SARS-CoV-2 virus in asymptomatic individuals and patients with mild disease, as well as to other important aspects of the immunology and epidemiology such as identification of serological correlates of protection, virus transmission, and epigenomic and transcriptomic profiling. Additionally, she is interested in vaccines against virus infections, and has actively participated in several studies analyzing the immune response to influenza and SARS-CoV-2 vaccines.